LATEST

Pair of genes may predict prostate cancer metastasisOverexpression of a specific pair of genes might provide early warning of prostate cancer patients’ likelihood of progressing to metastatic disease.
Why you need to better counsel PCa patients on sexual functionThere’s a troubling disconnect between low-risk prostate cancer patients’ desire to preserve sexual function and the treatment choices they and their doctors often make.
MedPAC advocates for MIPS terminationIf members of the Medicare Payment Advisory Commission have their way, the new Merit-based Incentive Payment System will be sent into oblivion, never to be heard of again.
Senate takes aim at pharmacy benefit managers’ role in rising drug costsA recently proposed bill “offers transparency measures that provide stakeholders further elucidation of how money moves through the pharmaceutical supply chain,” writes the AACU’s Brian Henderson.
How to get reimbursed for BPH water vapor ablation
SNS vs. botulinum: Caveats, considerations
How to choose between Roth, traditional accounts
How to reduce opioid use in post-op patientsIn this interview, urologist Francis J. McGovern, MD, discusses the scope of the problem of opioid abuse, outlines opioid-sparing strategies, and explains what the future holds in this area.
IC/BPS: One-fourth of patients have Hunner lesionsAbout one-fourth of patients with interstitial cystitis/bladder pain syndrome have Hunner lesions in the bladder visible on cystoscopy.
Immediate post-TURBT mitomycin instillation reduces recurrence riskMitomycin C instillation within 24 hours after transurethral resection of non-muscle invasive bladder cancer significantly reduces the risk of recurrence and delays the time to recurrence.

Poll